Arcutis Biotherapeutics, Inc. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arcutis Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Arcutis Biotherapeutics, Inc. for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Option Exercise | C | 0.00 | 2,825,602 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | P | 17.00 | 294,117 | 4,999,989 | 3,979,292 | 3.7 M to 4 M (+7.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 859,573 | 0 | 3,685,175 | 2.8 M to 3.7 M (+30.42 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Bain Capital Life Sciences Inv ... | 10% Owner | Buy | C | 0.00 | 2,825,602 | 0 | 2,825,602 | 0 to 2.8 M |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 1,074,467 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 2,099,019 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Option Exercise | C | 0.00 | 6,360,272 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Buy | P | 17.00 | 500,000 | 8,500,000 | 10,542,790 | 10 M to 10.5 M (+4.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Buy | C | 0.00 | 1,074,467 | 0 | 10,042,790 | 9 M to 10 M (+11.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Buy | C | 0.00 | 2,099,019 | 0 | 8,968,323 | 6.9 M to 9 M (+30.56 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Heron Patrick J | Director | Buy | C | 0.00 | 6,360,272 | 0 | 6,869,304 | 509 K to 6.9 M (+1,249.48 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 1,074,467 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 2,099,019 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 6,360,272 | 0 | 0 | |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | P | 17.00 | 500,000 | 8,500,000 | 10,542,790 | 10 M to 10.5 M (+4.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 1,074,467 | 0 | 10,042,790 | 9 M to 10 M (+11.98 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 2,099,019 | 0 | 8,968,323 | 6.9 M to 9 M (+30.56 %) |
| Feb 06 2020 | ARQT | Arcutis Biotherape ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 6,360,272 | 0 | 6,869,304 | 509 K to 6.9 M (+1,249.48 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 429,786 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,825,603 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 429,786 | 0 | 606,286 | 176.5 K to 606.3 K (+243.50 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 859,573 | 0 | 4,067,564 | 3.2 M to 4.1 M (+26.79 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | C | 0.00 | 2,825,603 | 0 | 3,207,991 | 382.4 K to 3.2 M (+738.94 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 176,500 | 3,000,500 | 176,500 | 0 to 176.5 K |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | ORBIMED ADVISORS LLC | Director | Buy | P | 17.00 | 382,388 | 6,500,596 | 382,388 | 0 to 382.4 K |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 429,786 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 859,573 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 2,825,603 | 0 | 0 | |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 429,786 | 0 | 606,286 | 176.5 K to 606.3 K (+243.50 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 859,573 | 0 | 4,067,564 | 3.2 M to 4.1 M (+26.79 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,825,603 | 0 | 3,207,991 | 382.4 K to 3.2 M (+738.94 %) |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 17.00 | 176,500 | 3,000,500 | 176,500 | 0 to 176.5 K |
| Feb 04 2020 | ARQT | Arcutis Biotherape ... | SILVERSTEIN JONATHAN | Director | Buy | P | 17.00 | 382,388 | 6,500,596 | 382,388 | 0 to 382.4 K |
| Feb 03 2020 | ARQT | Arcutis Biotherape ... | TURNER JOSEPH L | Director | Option Exercise | A | 17.00 | 37,500 | 637,500 | 37,500 |